Ipilimumab & Nivolumab Achieve 100% DFS in dMMR Colon CancerIpilimumab & Nivolumab Achieve 100% DFS in dMMR Colon Cancer Sep 16, 2024
HS-20093 Shows Promise in ES-SCLC: Efficacy and Safety ResultsHS-20093 Shows Promise in ES-SCLC: Efficacy and Safety Results Sep 16, 2024
SG vs Docetaxel: OS Benefit in mNSCLC After Anti-PD-(L)1SG vs Docetaxel: OS Benefit in mNSCLC After Anti-PD-(L)1 Sep 16, 2024
Plinabulin + Docetaxel Improves Survival in Advanced NSCLCPlinabulin + Docetaxel Improves Survival in Advanced NSCLC Sep 16, 2024